These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

5866 related articles for article (PubMed ID: 18271306)

  • 1. Spin-labeled rifamycin: biological activity.
    Raykov ZZ; Vassilev K; Grigorova G; Lyapova A; Alexiev A; Petrov G
    Pharmazie; 2008 Jan; 63(1):61-6. PubMed ID: 18271306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel rifamycins. I-Synthesis and antibacterial activity of 3-hydrazinorifamycin derivatives.
    Marsili L; Franceschi G; Gioia B; Oronzo G; Schioppacassi G; Vigevani A
    Farmaco Sci; 1982 Oct; 37(10):641-50. PubMed ID: 6814953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antibacterial activity of a new 3-azinomethyl-rifamycin.
    Strippoli V; Bruzzese T; Galli R; Simonetti N; Tronci N
    Farmaco Sci; 1988; 43(7-8):619-25. PubMed ID: 3147199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological activity of some derivatives of rifamycin P.
    Cavalleri B; Turconi M; Tamborini G; Occelli E; Cietto G; Pallanza R; Scotti R; Berti M; Romanó G; Parenti F
    J Med Chem; 1990 May; 33(5):1470-6. PubMed ID: 2329569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel rifamycins. III. Synthesis and antibacterial activity of 3-amidino- and of 4-aminoimidazolo[4,5-c]rifamycin derivatives.
    Marsili L; Franceschi G; Ballabio M; Oronzo G; Vigevani A; Ungheri D; Della Bruna C; Sanfilippo A
    J Antibiot (Tokyo); 1983 Nov; 36(11):1495-501. PubMed ID: 6418702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, crystal structure and anticancer activity of novel derivatives of ethyl 1-(4-oxo-8-aryl-4,6,7,8-tetrahydroimidazo[2,1-c][1,2,4]triazin-3-yl)formate.
    Sztanke K; Rzymowska J; Niemczyk M; Dybała I; Kozioł AE
    Eur J Med Chem; 2006 Apr; 41(4):539-47. PubMed ID: 16545495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and antibacterial evaluation of 1beta-methyl-2-[5-(1-methoxyimino-2-substituted sulfonamide ethyl)pyrrolidin-3-ylthio]carbapenems and their related compounds.
    Jeon H; Jo NH; Yoo KH; Choi JH; Cho H; Cho JH; Oh CH
    Eur J Med Chem; 2007 Mar; 42(3):358-64. PubMed ID: 17156896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antibacterial activity of some ester, amides, and hydrazides of 3-carboxyrifamycin S. Relationship between structure and activity of ansamycins.
    Bellomo P; Marchi E; Mascellani G; Brufani M
    J Med Chem; 1981 Nov; 24(11):1310-4. PubMed ID: 7310806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antiproliferative activity in vitro of diacetylenic thioquinolines.
    Mól W; Naczyński A; Boryczka S; Wietrzyk J; Opolski A
    Pharmazie; 2006 Sep; 61(9):742-6. PubMed ID: 17020147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure and evaluation of antibacterial and antitubercular properties of new basic and heterocyclic 3-formylrifamycin SV derivatives obtained via 'click chemistry' approach.
    Pyta K; Klich K; Domagalska J; Przybylski P
    Eur J Med Chem; 2014 Sep; 84():651-76. PubMed ID: 25063947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antimicrobial activity of substituted benzimidazole, benzothiazole and imidazole derivatives.
    Küçükbay H; Cetinkaya E; Durmaz R
    Arzneimittelforschung; 1995 Dec; 45(12):1331-4. PubMed ID: 8595095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, docking and antibacterial studies of more potent amine and hydrazone rifamycin congeners than rifampicin.
    Pyta K; Janas A; Szukowska M; Pecyna P; Jaworska M; Gajecka M; Bartl F; Przybylski P
    Eur J Med Chem; 2019 Apr; 167():96-104. PubMed ID: 30769243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 8-Deoxy-Rifamycin Derivatives from
    Ye F; Shi Y; Zhao S; Li Z; Wang H; Lu C; Shen Y
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32887371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemistry and biological activity of a tryptamine and beta-carboline series of bases.
    Begum S; Usmani SB; Siddiqui BS; Saeed SA; Farnaz S; Khan KA; Khan SA; Khalid SM; Zia A
    Arzneimittelforschung; 1996 Dec; 46(12):1163-8. PubMed ID: 9006793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New long-acting 3-azinomethyl-rifamycins.
    Bruzzese T; Cedro A; Dell'Acqua E; Di Nardo A; Goi A
    Farmaco Sci; 1986 Mar; 41(3):196-204. PubMed ID: 3709786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New C25 carbamate rifamycin derivatives are resistant to inactivation by ADP-ribosyl transferases.
    Combrink KD; Denton DA; Harran S; Ma Z; Chapo K; Yan D; Bonventre E; Roche ED; Doyle TB; Robertson GT; Lynch AS
    Bioorg Med Chem Lett; 2007 Jan; 17(2):522-6. PubMed ID: 17070048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on pyrazine derivatives. XLVII. Synthesis and antibacterial activity of novel pyrazine derivatives with amidoxime moiety.
    Gobis K; Foks H; Kedzia A; Wierzchowska M; Kwapisz E; Zwolska Z; Augustynowicz-Kopeć E
    Acta Pol Pharm; 2006; 63(1):39-45. PubMed ID: 17515328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new furobenzopyranone and other constituents from Anaphalis lactea.
    Wang AX; Zhang Q; Jia ZJ
    Pharmazie; 2004 Oct; 59(10):807-11. PubMed ID: 15544063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antibacterial activities of new bis-benzimidazoles.
    Küçükbay H; Durmaz R; Okuyucu N; Günal S; Kazaz C
    Arzneimittelforschung; 2004; 54(1):64-8. PubMed ID: 14979611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a Dual-Acting Antibacterial Agent (TNP-2092) for the Treatment of Persistent Bacterial Infections.
    Ma Z; Lynch AS
    J Med Chem; 2016 Jul; 59(14):6645-57. PubMed ID: 27336583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 294.